TAREQ
Name: Tareq
Diagnosis: Diabetes
D.O.B: 02 March 1970
Gender: Male
Country: United Arab Emirates
HISTORY
Nine years ago, Patient Tareq started suffering from what were later diagnosed as the symptoms of diabetes. He was eventually diagnosed at his local hospital in the UAE with Type-2 Diabetes.
Patient Tareq became reliant upon daily diabetic medication to control his blood sugar. In order to improve the function of the islet cells of his pancreas, and prevent diabetic complications, Patient Tareq began to investigate, with the help of the patient specialists at Puhua International Hospital in Beijing, the possibility of Cellular Therapy for his diabetic condition. After learning the details of the procedure, and having his questions answered by the patient representatives and physicians, he decided to travel to Beijing to receive Cellular Therapy at Puhua International Hospital.
Patient Tareq was admitted to Puhua International Hospital on Oct. 8th 2011.
Medical Condition before Cellular Treatment for Type 2 Diabetes
Patient Tareq had originally presented with typical diabetic symptoms, including: thirst, frequent urination, weakness and loss of weight. The general medical regimen that he used to control his blood sugar was as follows: Amaryl/1pill/before lunch; Glucophage/1pill/after lunch; Glucophage/2pills/after dinner.
With the above medical regimen, his blood sugar was in acceptable control.
Cellular Treatment for Type 2 Diabetes Over Two Weeks at Puhua International Hospital
Cellular implantation via IV injection and interventional therapy; treatment to improve whole body blood circulation; treatment to enhance energy metabolism; treatment to enhance nutrient supply for nerve cells.
Medical Condition after Cellular Treatment for Type 2 Diabetes
Interview with Mr. Tareq http://youtu.be/ISfSU1_dUVk
On Oct. 20th 2011, Tareq was discharged from PIH.
By about one month after his Cellular Therapy, Patient Tareq had been able to discontinue his daily (Amaryl) entirely. Further, his need for Glucophage had been reduced to only one pill in the morning and one pill at night.
Patient Tareq said he was now motivated do even better by doing more physical exercise.